|
|
||||||||
OPEN ACCESS ARTICLE
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EMBRYONIC STEM CELLS |
aDepartment of Pediatric Cardiology, University of Cologne, Cologne, Germany;
bInstitute of Neurophysiology, University of Cologne, Cologne, Germany;
cDepartment of Molecular and Cellular Sports Medicine, German Sport University, Cologne, Germany
Key Words. Pluripotent stem cells • Myocardial contraction • Cell transplantation • Myocardial infarction • Transplants
Correspondence: Jürgen Hescheler, M.D., Institute of Neurophysiology, University of Cologne, 50931 Cologne, Robert-Koch-Str. 39, Germany. Telephone: ++49-(0)-221-6960; Fax: ++49-(0)-221-3834; e-mail: J.Hescheler{at}uni-koeln.de
Received February 17, 2006;
accepted for publication August 28, 2006.
First published online in STEM CELLS EXPRESS September 14, 2006.
Human embryonic stem cell (hESC)-derived cardiomyocytes have been suggested for cardiac cell replacement therapy. However, there are no data on loaded contractions developed by these cells and the regulation thereof. We developed a novel in vitro transplantation model in which beating cardiomyocytes derived from hESCs (line H1) were isolated and transplanted onto noncontractile, ischemically damaged ventricular slices of murine hearts. After 23 days, transplanted cells started to integrate mechanically into the existing matrix, resulting in spontaneous movements of the whole preparation. Preparations showed a length-dependent increase of active tension. In transplanted early beating hESC-derived cardiomyocytes, frequency modulation by field stimulation was limited to a small range around their spontaneous beating rate. Our data demonstrate that this novel in vitro transplantation model is well suited to assess the mechanical properties and functional integration of cells suggested for cardiac replacement strategies.
This article has been cited by other articles:
![]() |
W. Habeler, S. Pouillot, A. Plancheron, M. Puceat, M. Peschanski, and C. Monville An in vitro beating heart model for long-term assessment of experimental therapeutics Cardiovasc Res, November 26, 2008; (2008) cvn299v2. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
